Pharmafile Logo
Pharmafocus logo
Advanced Search
nice_new_london_office_internal_3_web

NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease

March 4, 2020
Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease

UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …

News
48317770967_48ec28d656_b

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

March 4, 2020
Research and Development COVID-19, Chinese Coronavirus, Trump, Wuhan Coronavirus, coronavirus

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus …

News
pd36-1-ksc-20170808-ph_csh01_0023

MSD’s Phase 3 study of lymphoma treatment meets primary endpoints

March 3, 2020
Manufacturing and Production B-cell lymphoma, classical Hodgkin Lymphoma, lymphoma

MSD announced that its Phase 3 study of Keytruda (pembrolizumab) for the treatment of adults with relapsed or refractory classical …

News
gilead_hq_at_stockley_park_london_2

Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal

March 3, 2020
Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma

Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …

News
1024px-u

Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case

March 3, 2020
Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing

Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …

News

Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma

March 3, 2020
Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma

Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …

News
surgery-in-hospital-clinic-and-doctors-206-small

99% of Doctors feel NHS is not ready to deal with coronavirus, new survey finds

March 3, 2020
Manufacturing and Production Boris, Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Most NHS doctors, that partcipated in a survey, feel the organization is not well prepared to deal with a major …

News
michael-jewell

Funding overview for the pharmaceutical industry and outlook for 2020

March 2, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …

Feature
gwpharma

GW Pharma takes back control of UK Sativex sales from Bayer

March 2, 2020
Sales and Marketing Bayer, GW Pharma, Sativex, UK

British firm GW Pharmaceuticals has revealed that it plans to reclaim the commercialisation rights to market its cannabis-based multiple sclerosis …

News
26629351446_42eeafa009_b_1

UK Health Secretary says no tactics will be “off the table” in dealing with coronavirus

March 2, 2020
Sales and Marketing Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

British Health Secretary Matt Hancock has said nothing will be “off the table” in tackling the coronavirus as cases in …

News
martin_shkreli_2016

FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim

March 2, 2020
Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma

The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …

News
1024px-u

Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces

March 2, 2020
Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance

The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …

News
170124-f-ds634-005

Experimental drug could treat dyskinesia in people with Parkinson’s

March 2, 2020
Sales and Marketing Parkinson's, Parkinson's disease, dyskinesia, spasms

Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …

News
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative colitis and Crohn’s

February 28, 2020
Medical Communications, Sales and Marketing CHMP, EMA, Takeda, vedolizumab

Takeda’s subcutaneous formulation of its gut-selective biologic vedolizumab has secured recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus

The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …

News
fda2outsideweb

Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting

February 28, 2020
Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma

UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …

News
transportation_isolation_system

First coronavirus case confirmed in Wales as number of infected in Britain rises to 19

February 28, 2020
Medical Communications British Coronavirus, Chinese Coronavirus, Wales coronavirus, Wuhan Coronavirus, coronavirus

A person has been diagnosed with coronavirus in Wales, with the number of infected continuing to rise as numerous sporting …

News
6684097669_b859b7ea96_b

E. coli strain in the gut may increase risk of bowel cancer, new study finds

February 28, 2020
Medical Communications Cancer, E. coli, bowel cancer, bowels, cancer research, e coli, oncology

A type of E. coli infection may increase a person’s chance of developing bowel cancer, according to a new study …

News
pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

February 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes

The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …

News
lilly_entrance_web

FDA advisory committee narrowly backs Eli Lilly’s Cyramza combo for metastatic EGFR+ NSCLC

February 27, 2020
Sales and Marketing Eli Lilly, FDA, cyramza, pharms

Eli Lilly’s Cyramza (ramucirumab) has edged closer to US approval after it scored a recommendation from the FDA’s Oncologic Drugs …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026